Table 5.

Treatment CFRs for all studies

	# studies	Pooled treatment CFR, % (95% CI)	τ2
Overall	211	5.16 (4.20 to 6.34)	1.961
Adult	73	4.62 (3.17 to 6.75)	2.155
Paediatric	27	6.50 (2.65 to 10.36)	3.463
HIV−	52	3.33 (2.00 to 5.52)	2.640
HIV+	35	10.91 (7.68 to 15.50)	0.900
Drug sensitive	104	3.58 (2.59 to 4.97)	2.389
Drug resistant	43	14.06 (10.15 to 19.49)	0.921
Public sector	193	5.40 (4.39 to 6.64)	1.811
Private sector	14	Not pooled	4.058
Primary/secondary centre	91	5.18 (4.07 to 6.60)	1.247
Tertiary centre	116	4.87 (3.42 to 6.94)	2.936

Private sector was not pooled due to high heterogeneity.

CFR, case fatality ratio.